They investigated the expression patterns of molecules such as the immuno-related protein BRCA-1 and the anti-inflammatory and antioxidant-related transcription factor NRF2 in a range of malignancies at the genomic, protein expression, and clinical levels, as well as tumour immunologic analysis. This evidence concerns the gene BRCA1 and neoplasm.